To date, this gradient had been largely reported in CRC [10, 11, 15, 22], with higher expression of EGFR in the front of tumor invasion vs the surface of the tumor, and in metastasis localizations compared to the primary tumor. Here, EGFR is linked to colorectal carcinoma.